Market By Cgms Component Type, Cgms End-user, Cgms Demographics, Smbg Type, Smbg End-user And Smbg Application | Forecast 2019-2025
A Triton Market Research report states that the continuous glucose monitoring system comprising (CGMS) and self-monitoring of blood glucose (SMBG) market in China is expected to grow in terms of revenue with a CAGR of 25.62% and 9.36% respectively, during the forecast period 2019 to 2025.
The strategic initiatives formed by big companies are driving the growth of the China glucose monitoring system market during the forecast period. For instance, in January 2016, Medtronic strategized a partnership with the Chengdu municipal government to deploy and manufacture advanced diabetes treatments in Chengdu, China. As part of the settlement, Medtronic capitalized in a manufacturing facility for a next-generation sensor-augmented pump scheme with SmartGuard technology to aid advance diabetes management for the rising diabetes populace in China. In addition, Medtronic partners with the Chengdu administration to allow individuals with diabetes in Chengdu and the wider Sichuan jurisdiction to access this new, locally-produced technology with software displayed in the Chinese language. Moreover, in May 2013, Medtronic entered into a partnership with the National Institute of Hospital Administration, a think tank under China’s National Health & Family Planning Commission, to release a series of exploration plans focused on constructing an integrated care path for patients with Type 1 diabetes.
Because of the high costs of devices, such as the continuous glucose monitors and the lack of proper reimbursement, patients are forced to spend out of their own pockets. The absence of reimbursement and insurance coverage constrains the use of blood glucose monitoring devices for those who can afford to pay, which is restraining the market growth.
Triton Market Research’s report on the China glucose monitoring system market provides in-depth insight and segmentation analysis of the market. The detailed analysis of the market includes the key buying criteria, PESTEL analysis, value chain analysis, the incidence of diabetes in China, healthcare service in China and the market attractiveness index. The segmentation analysis of the China glucose monitoring system market includes the market by CGMS component type, by CGMS end-user, by CGMS demographics, by SMBG type, by SMBG end-user and by SMBG application.
The companies competing in the China glucose monitoring system market are Apex Biotechnology Corp, Medtronic, Abbott Laboratories, Roche Diagnostics, Becton Dickinson and Company, Johnson & Johnson, Sinocare, B Braun Melsungen AG, ARKRAY Inc, and Yones Toptech (China) Co Ltd
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. CHINA GLUCOSE MONITORING SYSTEM MARKET - SUMMARY
1.2.
MARKET DRIVING ASPECTS
1.3.
MARKET RESTRAINING ASPECTS
1.4. KEY PLAYERS
2. CHINA
GLUCOSE MONITORING SYSTEM INDUSTRY OUTLOOK
2.1. MARKET
DEFINITION
2.2. PESTEL
ANALYSIS
2.2.1. POLITICAL
2.2.2. ECONOMICAL
2.2.3. SOCIAL
2.2.4. TECHNOLOGICAL
2.2.5. LEGAL
2.2.6. ENVIRONMENTAL
2.3. HEALTHCARE
SERVICE IN CHINA
2.4. KEY
BUYING CRITERIA
2.5. INCIDENCE
OF DIABETES IN CHINA
2.6. VALUE
CHAIN ANALYSIS
2.7. MARKET
ATTRACTIVENESS INDEX
3. CHINA
GLUCOSE MONITORING SYSTEM MARKET - SEGMENTATION
3.1. BY CGMS COMPONENT TYPE (SENSORS, TRANSMITTER AND RECEIVERS, INTEGRATED INSULIN PUMPS)
3.2. BY CGMS END USER (HOME SETTINGS, DIAGNOSTICS AND CLINICAL, HOSPITAL)
3.3. BY CGMS DEMOGRAPHICS (ADULT POPULATION (>14YEARS), CHILD POPULATION (>14YEARS))
3.4. BY SMBG TYPE (TEST STRIPS, GLUCOSE METER, LANCETS)
3.5. BY SMBG END USER (HOME SETTINGS, CLINICAL, HOSPITAL)
3.6. BY SMBG APPLICATION (TYPE 1 DIABETES, TYPE 2 DIABETES, GESTATIONAL DIABETES)
4. COMPETITIVE
LANDSCAPE
4.1. ABBOTT
4.2. APEX
BIOTECHNOLOGY CORP.
4.3. ARKRAY,
INC.
4.4. B
BRAUN MELSUNGEN AG
4.5. BECTON
DICKINSON AND COMPANY
4.6. JOHNSON
& JOHNSON
4.7. MEDTRONIC
4.8. ROCHE
DIAGNOSTICS
4.9. SINOCARE
4.10. YONES TOPTECH (CHINA) CO.,
LTD.
5. RESEARCH
METHODOLOGY & SCOPE
5.1. RESEARCH
SCOPE & DELIVERABLES
5.1.1. OBJECTIVES
OF STUDY
5.1.2. SCOPE
OF STUDY
5.2. SOURCES
OF DATA
5.2.1. PRIMARY
DATA SOURCES
5.2.2. SECONDARY
DATA SOURCES
5.3. RESEARCH
METHODOLOGY
5.3.1. EVALUATION
OF PROPOSED MARKET
5.3.2. IDENTIFICATION
OF DATA SOURCES
5.3.3. ASSESSMENT
OF MARKET DETERMINANTS
5.3.4. DATA
COLLECTION
5.3.5. DATA VALIDATION &
ANALYSIS
TABLE 1 CHINA GLUCOSE MONITORING SYSTEM MARKET 2019-2025
($ MILLION)
TABLE 2 AVERAGE PRICES OF GLUCOSE TEST STRIPS,
LANCETS AND GLUCOSE METER IN CHINA (US $)
TABLE 3 CHINA - COUNTRY SNAPSHOT
TABLE 4 CHINA GLUCOSE MONITORING SYSTEM MARKET
BY CGMS COMPONENT TYPE 2019-2025 ($ MILLION)
TABLE 5 CHINA GLUCOSE MONITORING SYSTEM MARKET
BY CGMS END-USER 2019-2025 ($ MILLION)
TABLE 6 CHINA GLUCOSE MONITORING SYSTEM MARKET
BY CGMS DEMOGRAPHICS 2019-2025 ($ MILLION)
TABLE 7 CHINA GLUCOSE MONITORING SYSTEM MARKET
BY SMBG TYPE 2019-2025 ($ MILLION)
TABLE 8 CHINA GLUCOSE MONITORING SYSTEM MARKET
BY SMBG END-USER 2019-2025 ($ MILLION)
TABLE 9 CHINA GLUCOSE MONITORING SYSTEM MARKET
BY SMBG APPLICATION 2019-2025 ($ MILLION)
FIGURE 1 CHINA GLUCOSE MONITORING SYSTEM MARKET
2019-2025 ($ MILLION)
FIGURE 2 CHINA SMBG SALES CHANNEL 2019-2025 ($
MILLION)
FIGURE 3 VALUE CHAIN ANALYSIS OF CGMS MARKET
FIGURE 4 MARKET ATTRACTIVENESS INDEX